Incannex Healthcare (IXHL) Other Non Operating Income (2023 - 2026)
Incannex Healthcare (IXHL) posted Other Non Operating Income of $25000.0 for Q1 2026, up 204.17% sequentially from -$24000.0 in Q4 2025, and up 102.52% YoY from $12344.8 in Q1 2025.
Incannex Healthcare (IXHL) Other Non Operating Income (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Other Non Operating Income for 4 years, with the latest figure at $25000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 102.52% year-over-year to $25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$490000.0 (up 63.32% YoY) and the FY2025 annual result came in at -$1.5 million, down 5157.14% from the prior year.
- Other Non Operating Income improved to $25000.0 in Q1 2026 per IXHL's latest filing, from -$24000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $25000.0 in Q1 2026 and troughed at -$994000.0 in Q1 2025.
- A 4-year average of -$167636.4 and a median of -$11000.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income slumped 8936.36% in 2025, then jumped 102.52% in 2026.
- Over 4 years, Other Non Operating Income stood at -$5000.0 in 2023, then slumped by 6420.0% to -$326000.0 in 2024, then surged by 92.64% to -$24000.0 in 2025, then surged by 204.17% to $25000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $25000.0, -$24000.0, and -$13000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Incannex Healthcare | 41.74 Mn | 41.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -478,000.00 |
| Mar 31, 2025 | -994,000.00 |
| Dec 31, 2024 | -326,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | -5,000.00 |
| Sep 30, 2023 | -2,000.00 |